Background: Elevated blood lead levels (EBLLs; ≥5 µg/dL) are more prevalent among refugee children resettled in the United States than the general US population and contribute to permanent health and neurodevelopmental problems. The Centers for Disease Control and Prevention recommends screening of refugee children aged 6 months to 16 years on arrival in the United States and retesting those aged 6 months to 6 years between 3- and 6-months postarrival.
Methods: We analyzed EBLL prevalence among refugee children aged 6 months to 16 years who received a domestic refugee medical examination between January 1, 2010 and September 30, 2014.
The domestic refugee screening is a valuable tool to link newly arrived refugees to the US health care system and can assist in providing a continuum of care from overseas to arrival. Beyond initial refugee screening, accessing general medical, dental, and mental health services can be significantly challenging.
View Article and Find Full Text PDF